The Brain Cholinergic System in Neurodegenerative Diseases

References (111)

1. 1 The Cholinergic Hypothesis of Geriatric Memory Dysfunction [DOI]
2. 2 Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations [DOI]
3. 3 Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey [DOI]
4. 4 Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor [DOI]
5. 5 Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors [DOI]
6. 6 Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition [DOI]
7. 7 Neurotrophin signaling through the p75 neurotrophin receptor [DOI]
8. 8 Basal forebrain neurons in the dementia of Parkinson disease [DOI]
9. 9 ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury [DOI]
10. 10 Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease [DOI]
11. 11 Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum [DOI]
12. 12 Dementia in Parkinson disease [DOI]
13. 13 Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice [DOI]
14. 14 Cholinergic Dysfunction in Parkinson’s Disease [DOI]
15. 15 Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease [DOI]
16. 16 Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients [DOI]
17. 17 Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease [DOI]
18. 18 Cholinergic systems mediate action from movement to higher consciousness [DOI]
19. 19 From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease [DOI]
20. 20 Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease [DOI]
21. 21 The organization and some projections of cholinergic neurons of the mammalian forebrain [DOI]
22. 22 Memory and cognitive function in man [DOI]
23. 23 Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system [DOI]
24. 24 Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor [DOI]
25. 25 Cholinergic dysfunction in diseases with Lewy bodies [DOI]
26. 26 β-Amyloid-Induced Inflammation and Cholinergic Hypofunction in the Rat Brain in Vivo: Involvement of the p38MAPK Pathway [DOI]
27. 27 Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy [DOI]
28. 28 Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation [DOI]
29. 29 Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
30. 30 Loss of neurons in the rat basal forebrain cholinergic projection system after prolonged intake of ethanol [DOI]
31. 31 Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats [DOI]
32. 32 Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation [DOI]
33. 33 Long-term ethanol consumption by rats: Effect on acetylcholine release in vivo, choline acetyltransferase activity, and behavior [DOI]
34. 34 Cholinesterase Inhibitor Therapy Stabilizes Symptoms of Alzheimer Disease [DOI]
35. 35 The basal nucleus of Meynert in patients with progressive supranuclear palsy [DOI]
36. 36 Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease [DOI]
37. 37 Chapter 33 Effects of trophic factors on the CNS cholinergic phenotype [DOI]
38. 38 Dopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice [DOI]
39. 39 The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology [DOI]
40. 40 Choline acetyltransferase immunohistochemistry in brains of alzheimer's disease patients and controls [DOI]
41. 41 Distribution of neuronal receptors for nerve growth factor in the rat [DOI]
42. 42 The substantia innominata in alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes [DOI]
43. 43 Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—II. Brainstem, cerebellum and spinal cord [DOI]
44. 44 Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
45. 45 Immunohistochemical evidence for a possible somatostatin-containing amygdalostriatal pathway in normal and Alzheimer's disease brain [DOI]
46. 46 Lewy body dementia — clinical, pathological and neurochemical interconnections [DOI]
47. 47 Pro-domain in precursor nerve growth factor mediates cell death [DOI]
48. 48 Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats [DOI]
49. 49 Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle [DOI]
50. 50 Cholinergic enzymes in the spinal cord in Alzheimer-type dementia [DOI]
51. 51 Alzheimer's Disease: The Amyloid Cascade Hypothesis [DOI]
52. 52 Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain [DOI]
53. 53 SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE [DOI]
54. 54 Amyloid deposition as the central event in the aetiology of Alzheimer's disease [DOI]
55. 55 The role of acetylcholine in learning and memory [DOI]
56. 56 NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA [DOI]
57. 57 The cholinergic system in aging and neuronal degeneration [DOI]
58. 58 Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease [DOI]
59. 59 Microglial dysfunction in brain aging and Alzheimer's disease [DOI]
60. 60 The cholinergic system and Parkinson disease [DOI]
61. 61 Synaptic loss in Alzheimer's disease and other dementias [DOI]
62. 62 In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease [DOI]
63. 63 Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. [DOI]
64. 64 A mitochondrial etiology of Alzheimer and Parkinson disease [DOI]
65. 65 The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic DystrophyIn VitroandIn Vivo [DOI]
66. 66 Complete morphologies of basal forebrain cholinergic neurons in the mouse [DOI]
67. 67 Progression of Tau Pathology in Cholinergic Basal Forebrain Neurons in Mild Cognitive Impairment and Alzheimer's Disease [DOI]
68. 68 Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome [DOI]
69. 69 Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice [DOI]
70. 70 Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic Denervation [DOI]
71. 71 A POST-MORTEM STUDY OF THE CHOLINERGIC AND GABA SYSTEMS IN SENILE DEMENTIA [DOI]
72. 72 Phenotypic Knockout of Nerve Growth Factor in Adult Transgenic Mice Reveals Severe Deficits in Basal Forebrain Cholinergic Neurons, Cell Death in the Spleen, and Skeletal Muscle Dystrophy [DOI]
73. 73 Differential effects of amyloid peptides β-(1–40) and β-(25–35) injections into the rat nucleus basalis [DOI]
74. 74 Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines [DOI]
75. 75 Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy [DOI]
76. 76 Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly [DOI]
77. 77 Hippocampal ProNGF Signaling Pathways and β-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease [DOI]
78. 78 Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders [DOI]
79. 79 Vesicular Acetylcholine Transporter Density and Alzheimer’s Disease [DOI]
80. 80 Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia [DOI]
81. 81 An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson’s disease [DOI]
82. 82 Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors [DOI]
83. 83 Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology? [DOI]
84. 84 Mitochondria and Alzheimer's disease [DOI]
85. 85 Progressive supranuclear palsy [DOI]
86. 86 The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat [DOI]
87. 87 Transmitter deficits in Alzheimer's disease [DOI]
88. 88 Relationship Between Plaques, Tangles, and Loss of Cortical Cholinergic Fibers in Alzheimer Disease [DOI]
89. 89 Acetylcholine in the cerebral cortex [DOI]
90. 90 The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease [DOI]
91. 91 THE EFFECT OF THIAMINE DEFICIENCY ON THE ACETYLCOENZYMEA AND ACETYLCHOLINE LEVELS IN THE RAT BRAIN [DOI]
92. 92 Preservation of Brain Nerve Growth Factor in Mild Cognitive Impairment and Alzheimer Disease [DOI]
93. 93 Frontotemporal Dementia/Pick's Disease [DOI]
94. 94 Ethanol transiently suppresses choline-acetyltransferase in basal nucleus of Meynert slices [DOI]
95. 95 The AF64A-Treated Mouse: Possible Model for Central Cholinergic Hypofunction [DOI]
96. 96 Lewy Body Disease and Dementia [DOI]
97. 97 Neurof ibrillary tangles in chronic alcoholics [DOI]
98. 98 Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy [DOI]
99. 99 Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics [DOI]
100. 100 Frontotemporal Dementia: Implications for Understanding Alzheimer Disease [DOI]
101. 101 The neuropathology of aminergic nuclei in Alzheimer's disease [DOI]
102. 102 Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography [DOI]
103. 103 Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease [DOI]
104. 104 Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease [DOI]
105. 105 M1 Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy [DOI]
106. 106 Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain [DOI]
107. 107 Cholinergic vesicular transporters in progressive supranuclear palsy [DOI]
108. 108 Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes [DOI]
109. 109 Loss of motor units in Alzheimer's disease.
110. 110 Corticobasal syndrome: a field of uncertainty [DOI]
111. 111 Pharmacology and pathophysiology of dopaminergic neurons.

Cited by 23

Showing 13 of 23 known citations — external sources report more than can currently be individually listed.

Related research

• Regions and Sub-regions Dysfunctions in Alzheimer’s during Rest — shares topic coverage
• An Overview on the Aetiology and Treatment of Alzheimer's Disease — shares topic coverage
• Dementia Diagnosis and Alternate Treatment: A Recent Update on Treatment Options — shares topic coverage
• Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants — shares topic coverage
• En Attendant Centiloid — shares topic coverage